Literature DB >> 11370265

Primary cardiac lipoblastoma.

M K Dishop1, W N O'Connor, S Abraham, C M Cottrill.   

Abstract

Lipoblastoma is a benign adipose tumor in children that has been described in various anatomic locations, most commonly the extremities. We describe the case of a 17-month-old boy diagnosed with cardiac lipoblastoma, a previously unreported primary cardiac tumor in children. Our patient presented with symptoms of coughing, wheezing, and hoarseness and was found to have a large mediastinal mass, which narrowed the left mainstem bronchus and compressed the right atrium and superior vena cava, causing superior vena cava syndrome. Surgical exploration revealed an intrapericardial soft tissue mass arising from the area of the posterior interatrial septum. Grossly, the resected mass was lobulated, pale yellow, and fatty with focal areas of gray myxoid tissue. Microscopically, the tumor consisted of both immature and mature adipocytes, with focal vascular myxoid areas containing lipoblasts, diagnostic of lipoblastoma. Two months after surgery, the patient was in good health without evidence of recurrence.

Entities:  

Mesh:

Year:  2001        PMID: 11370265     DOI: 10.1007/s100240010176

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  4 in total

1.  Radiological-pathological correlation in lipoblastoma and lipoblastomatosis.

Authors:  Shruti Moholkar; Neil J Sebire; Derek J Roebuck
Journal:  Pediatr Radiol       Date:  2006-06-15

2.  Lipoblastoma: clinical features, treatment, and outcome.

Authors:  Kenneth Y Y Kok; P U Telisinghe
Journal:  World J Surg       Date:  2010-07       Impact factor: 3.352

Review 3.  Mesenchymal tumours of the mediastinum--part I.

Authors:  Michael A den Bakker; Alexander Marx; Kiyoshi Mukai; Philipp Ströbel
Journal:  Virchows Arch       Date:  2015-09-10       Impact factor: 4.064

Review 4.  Update of Pediatric Lipomatous Lesions: A Clinicopathological, Immunohistochemical and Molecular Overview.

Authors:  Eline Ameloot; Fleur Cordier; Jo Van Dorpe; David Creytens
Journal:  J Clin Med       Date:  2022-03-31       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.